Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

AN2 Therapeutics, Inc.

Pharmaceutical Preparations · Menlo Park, CA, United States

  1. PrincipalsEric EasomChief Executive OfficerLucy DayChief Financial OfficerSanjay ChandaChief Development Officerand 11 more
  2. CompanyAN2 Therapeutics, Inc.Menlo Park, CA, United States
  3. Phone line+1 (650) 331-9090General business
Request a quote

AN2 Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker ANTX) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 14

Chief executive

Eric EasomChief Executive Officer

Chair & board

Gilbert Lynn MarksDirector (Board)
Joseph S ZakrzewskiDirector (Board)
Kabeer AzizDirector (Board)
Margaret M FitzPatrickDirector (Board)

Finance

Lucy DayChief Financial Officer
Everyone else on file (4)
Sanjay ChandaChief Development Officer
Stephen David PriorChief Strategy Officer
Joshua M EizenOfficer (see SEC filing)
Sarah Joanne WilliamsPrincipal Accounting Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Eric Easom — Chief Executive Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Lucy Day — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Sanjay Chanda — Chief Development Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Stephen David Prior — Chief Strategy Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers